相关实验视频

Updated: May 7, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

基因检测在局部性前列腺癌中的作用

Rebecca A Sager¹, Gennady Bratslavsky²

¹Department of Surgery - Urology Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

The Urologic clinics of North America

|November 20, 2025

概括

基因检测对于管理局部性前列腺癌 (PCa) 是至关重要的. 识别生殖系变异有助于风险评估,并指导PCa患者的个性化查和治疗策略.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
基因组学就是基因组学.

背景情况:

基因检测对于局部性前列腺癌 (PCa) 管理至关重要.
下一代测序识别了影响PCa风险,预后和治疗的生殖线和体质变化.
10-15%的PCa患者携带病原性生殖系变异,特别是在BRCA2,ATM,CHEK2,HOXB13和不匹配修复基因中.

研究的目的:

突出基因检测在局部前列腺癌中日益重要的重要性.
总结目前对PCa的生殖线和体质变化的理解.
概述基因信息在指导PCa管理中的作用.

主要方法:

审查当前文学和关于前列腺癌遗传检测的指导方针.
分析PCa中生殖系变异的流行率和类型.
讨论基因组数据在临床决策中的应用.

主要成果:

发生在10-15%患有PCa的男性身上发现了生殖系变异.
涉及的关键基因包括BRCA2,ATM,CHEK2,HOXB13和不匹配修复基因.
对于特定的患者群体,建议进行常规的生殖线检测.

结论:

基因检测,包括生殖线和体质分析,是现代前列腺癌管理的组成部分.
基因组信息有助于量身定制查和治疗建议.
指南支持对高风险局部PCa和具有家族病史的人进行生殖线检测.

关键词:

这就是BRCA BRCA.修复DNA损伤的修复基因检测是一种基因检测.基因组分类器基因组分类器前列腺癌是什么意思前列腺癌是什么意思

更多相关视频

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...